- President, CEO
As the Founder of Clinlogix, LLC, JeanMarie Markham, RN, CCRA, is an inspiring leader who seeks to continually drive the field of Clinical Research Services forward. She has over 20 years of experience in the industry. In 1990, JeanMarie founded Markham & Associates to provide regional Clinical Monitoring and Investigator Management services to the Industry. She developed a national platform of experienced Clinical Research Associates to provide clients with regionally-based clinical monitoring services in multitherapeutic areas for the biopharmaceutical and medical device industries.
- Executive Vice President
Mike is the former Chairman of the Board and CEO of Sentrx, a leading pharmacovigilance service provider. Mike help build Sentrx into an industry leader in pharmacovigilance by rapidly scaling teams of highly skilled healthcare professionals with a focus on drug and device safety both in the clinical and post-marketed areas. In 2013, Sentrx was acquired by Telerx, a division of Merck.
- Vice President Business Development, Emerging Technologies
As Vice President of Business Development, Carlos brings a wide variety of experience from the start-up world to the corporate level, with a proven track record in multinational markets. His key strengths are the development and execution of strategic plans for companies in the healthcare and medical device industry. Carlos has more than twelve (12) years’ experience; building and managing teams through the development of innovative programs, multidisciplinary alliances and profitability models.
- Director, IT Services
For the past 30 years Chris has provided IT Project and Program Management skills to the Manufacturing, Banking, Nuclear, Energy, and BioPharmaceutical industry. Since 1995 Chris has worked exclusively in the biopharmaceutical industry.
- Country Manager - Clinlogix Latam S.A.S.
Paola has sixteen (16) years’ experience within clinical research, predominately Pharmaceutical and Medical Device studies. With seven (7) years’ experience working as a Research Director in two research centers, she has been responsible for 37 studies, with over 1,000 patients enrolled. Some of the therapeutic areas for the Pharmaceutical studies Paola has worked on include: Rheumatoid Arthritis, Osteoporosis, Lupus Erythematosus, Tuberous Sclerosis, Dermatological diseases, Cardiovascular Disease, high cholesterol, stroke, Chronic Migraine, Atrial Fibrillation, Metabolic Disorders, and Prevention of Mediastinitis.